Posts Tagged ‘Inspection’



Heading towards 100% CCI testing

In recent years, Container Closure Integrity (CCI) testing has steadily moved up the pharmaceutical manufacturing agenda. Apart from reducing the risk of product recalls, CCI testing proves to be less time-consuming than most sterility test methods and can lead to significant cost reductions. …more


Bosch invites you to Pharma Expo 2016

Bosch Packaging Technology will once again exhibit in booth W-603 at the entrance to the West Building at Pharma Expo in Chicago, on November 6-9. The booth will be full with displays and equipment from our broad pharmaceutical manufacturing portfolio, which offers the most complete range of solutions from a single-source supplier.

At Pharma Expo this year, Bosch will exhibit  …more


Automated Inspection – False Reject Mitigation with latest Mechanical, Vision and Sensor Technologies

AIM 8

The Inspection Technology Pharma (ITP) division of Bosch offers automated technologies to achieve highest detection levels for visible particle and container defects to ensure product and patient safety.

Technologies continue to develop and be applied in the field, with the goal of 100% defect detection and 0% false rejection as the targets. …more


Bosch Packaging Technology and Lighthouse Instruments: cooperation for automated headspace leak detection

Bosch Packaging Technology today announced a cooperation with Lighthouse Instruments, LLC, headquartered in Charlottesville, Virginia, USA. The cooperation will result in a new machine series for pharmaceutical container closure integrity (CCI) testing with laser headspace analysis (HSA) exclusively marketed by Bosch. To this end, Lighthouse will exclusively license and supply Bosch with laser measurement systems for automated pharmaceutical leak detection applications.

…more


Bosch Non-Destructive Leak Detection and Container Closure Integrity Technologies

The Inspection Technology Pharma (ITP) division of Bosch is poised to meet the growing demands for Leak Detection and Container Closure Integrity (CCI) testing in pharmaceutical and biological medicines.

Fused containers, such as glass ampoules, are required to be 100% integrity tested as per EU GMP Annex 1.  But other containers, such as vials, cartridges and syringes, filled with liquid or lyophilized products, are required to have a robust container closure process and testing evidence to assure product sterility and stability.  …more





Top of page